Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-01

Clinical Trial Update: Sumatriptan as Treatment for Post-traumatic Headache [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sumatriptan for post-traumatic headache has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

Sponsor: University of Washington | Conditions: Post-traumatic Headache | Phase 2 | Status: COMPLETED | Results posted: 2021-12-01